VIDO - USask
vido.org
VIDO - USask
@vido.org
The Vaccine and Infectious Disease Organization (VIDO) is a world leader in infectious disease research and vaccine development for humans and animals.
#HealthyPeopleHealthyAnimals #Canada'sCentreforPandemicResearch
VIDO scientists Dr. Antonio Facciuolo and Dr. Bryce Warner
@brycewarner1.bsky.social joined @usask.ca’s Signature Series Podcast to discuss their work on highly pathogenic avian influenza (HPAI), including new insights into HPAI in dairy cattle.🎧Tune in: news.usask.ca/articles/res...
Signature Series research podcast: Animal flus with Drs. Bryce Warner and Antonio Facciuolo - News
While avian flu and cattle flu aren’t quite the same as the flu we’re used to as humans, they can have deadly consequences for wild and farmed birds and long-term effects on our cows that we’re only j...
news.usask.ca
November 5, 2025 at 4:01 PM
Honoured to welcome His Excellency Matthias Lüttenberg, Ambassador of Germany to Canada, Hon. Consul Benedict E. Nussbaum and Ms. Ashli Blondeau to VIDO. Grateful for the opportunity to share our work in vaccine innovation and global health. @germanyincanada.bsky.social

@usask.ca
November 4, 2025 at 8:29 PM
Our Director & CEO, Dr. Volker Gerdts, shares how VIDO’s research is shaping the next generation of vaccines and advancing global health. Proud to be driving innovation from the Prairies: www.theglobeandmail.com/life/adv/art...
@usask.ca
Fifty years of research-driven vaccine innovation
Sponsor Content
www.theglobeandmail.com
November 4, 2025 at 5:23 PM
What if we could test antivirals on a “mini lung” before using them in people? Scientists at VIDO have created lab-made lung organoids that mimic real tissue and reveal how viruses infect specific lung cells... Read more: www.vido.org/news/2025/ho...
October 14, 2025 at 2:27 PM
VIDO, @usaskmed.bsky.social, and WCVM have received over $460K from @innovation.ca to bring cutting-edge cell sorting tech to campus! Housed at VIDO, this new hub will boost collaboration + speed discoveries that improve health for people & animals: www.vido.org/news/2025/ne... @usask.ca
October 10, 2025 at 5:19 PM
🌾It’s Agriculture Week in SK! From crops to livestock, ag is at the ❤️ of our province. We’re proud to support the sector by protecting animal health, advancing food security, and strengthening resilience in our food systems.
#CelebrateAg #HealthyPeopleHealthyAnimals
October 6, 2025 at 6:34 PM
Great to connect in Halifax with Philippe Hébert, Dir. Gen. at Defence Research and Development Canada and Canada’s representative on NATO DIANA. Strong partnerships are key to advancing research and innovation that strengthen Canada’s health security and global resilience. 🍁
#Collaboration
October 2, 2025 at 3:15 PM
What a week! 🎉From our Scientific Summit to the 50th Gala to celebrating our amazing team, thank you to everyone who joined us to mark 50 years of VIDO. The future of innovation, collaboration & impact starts now. #VIDOis50
@usask.ca
September 26, 2025 at 4:51 PM
50 years ago today the Veterinary Infectious Disease Organization, now Vaccine and Infectious Disease Organization, was founded at @usask.ca. Happy 50th Anniversary VIDO! #VIDOis50
September 25, 2025 at 2:16 PM
Coming up at #VIDOis50 Scientific Summit: Enabling Technologies.
Hear from innovators shaping the future of infectious disease research and vaccine development:
🔹 Dr. Nicolas Collin, Vaccine Formulation Institute
🔹Dr. Jean-Philippe Julien, Sick Kids
🔹 Dr. Steven Rayan, quanTA
September 23, 2025 at 7:54 PM
The Bacteriology session at the VIDO Scientific Summit is here! Global experts are sharing the latest on bacterial pathogens, disease mechanisms, and prevention strategies:
Dr. Joanne Flynn, Uni. of Pittsburgh
Dr. Jörg Jores, Uni. of Bern
Dr. Scott Gray-Owen, Uni. of Toronto
September 23, 2025 at 7:53 PM
🎉 VIDO is celebrating 50 years of protecting health, food security & advancing infectious disease research. From vaccines to pandemic response, we’re preparing the world for future threats. Read more: bit.ly/3KAvTPu
@usask.ca #VIDOis50
September 22, 2025 at 3:26 PM
Researchers at VIDO have identified a new TB gene that could help guide safer, more effective vaccines. Their new vaccine approach worked as well as BCG while avoiding interference with TB skin tests. 🌍💉Read more 👉 bit.ly/3Io7Z9e
@usask.ca @jeffchenmycolab.bsky.social
September 17, 2025 at 5:30 PM
🚨 We're hiring for an animal technician! Apply now to join our team: vido.applytojobs.ca/veterinary%2...
#WorkAtVIDO #WorkWithUs #Hiring #JoinOurTeam #ResearchCareers
September 16, 2025 at 6:54 PM
📢 Today, VIDO and the International Vaccine Institute in South Korea reaffirmed our commitment to global health by renewing our MOU to strengthen vaccine R&D and pandemic preparedness.

Read the full release: www.vido.org/news/2025/sa...

@usask.ca
September 8, 2025 at 3:29 PM
We were pleased to welcome Her Honour, the Honourable Lieutenant Governor of Saskatchewan Bernadette McIntyre and His Honour Rich McIntyre to meet the VIDO team and tour our facilities.
September 5, 2025 at 3:02 PM
📣📣 We are hiring! Do you love caring for animals? Our Veterinary Research Services Team is looking for an animal attendant! For more info or to apply: vido.applytojobs.ca/veterinary%2...
August 29, 2025 at 2:45 PM
New TB research! 🧫 A collab between VIDO & UBC shows the Parkinson’s drug benztropine may help immune cells fight TB. VIDO confirmed it works in infected mice using our CL3 labs. Great example of shared expertise in action.
🔗 www.nature.com/articles/s44...
#TBResearch #ScienceCollaboration
The Parkinson’s drug benztropine possesses histamine receptor 1-dependent host-directed antimicrobial activity against Mycobacterium tuberculosis - npj Antimicrobials and Resistance
npj Antimicrobials and Resistance - The Parkinson’s drug benztropine possesses histamine receptor 1-dependent host-directed antimicrobial activity against Mycobacterium tuberculosis
www.nature.com
August 13, 2025 at 5:32 PM
VIDO was proud to take part in the STI & HIV 2025 World Congress in Montreal this week. Our team shared insights on advancing vaccine research and emerging infectious diseases, and connected with global experts dedicated to improving public health. #STIHIV2025
July 30, 2025 at 2:38 PM
VIDO is hiring! Join us to advance vaccine R&D, safeguard biosafety, and ensure quality in global health.
✨ Vaccine Dev Project Manager
✨ QA/QC Specialist
✨ Assistant Biosafety Officer
Apply now: vido.org/careers/curr...
#NowHiring #Careers #WorkAtVIDO #WorkWithUs
July 25, 2025 at 2:24 PM
📣📣 We are hiring for a Vaccine Development Project Manager to coordinate scientific projects from proof-of-concept through to commercialization or out-licensing. For more info or to apply: vido.applytojobs.ca/vaccine%20de...

#WorkatVIDO #WorkWithUs
July 23, 2025 at 3:04 PM
Thank you to the @usaskmed.bsky.social Public Health & Preventive Medicine Residents for visiting VIDO today! You asked great questions, and we’re always glad to share how our work helps protect human and animal health. #USask #OneHealth @usask.ca
July 18, 2025 at 5:32 PM
📢 We have a new opportunity for a Laboratory Assistant to join our team! The successful candidate will provide ongoing support to the Media and Glass Prep laboratory. For more information or to apply, visit: vido.applytojobs.ca/laboratory/4...
#WorkAtVIDO #WorkWithUs
July 14, 2025 at 4:26 PM
🚨 We're hiring! Join our team and help advance global health.

Now recruiting for:
🐾 Animal Technician
🧪 Assistant Biosafety Officer
✅ QA/QC Specialist
🔬 Research Associate

Apply now and be part of something world-changing: www.vido.org/careers/curr...
#WorkAtVIDO #WorkWithUs #Hiring #JoinOurTeam
July 3, 2025 at 7:31 PM
Reposted by VIDO - USask
🚨Our new study out today in Nature Communications. Bats can asymptomatically host multiple viruses while remaining apparently healthy. Here we identify how interferon-mediated responses protect bats and identify molecular adaptations in GBP1. #LZCI
Link: www.nature.com/articles/s41...
Bat-specific adaptations in interferon signaling and GBP1 contribute to enhanced antiviral capacity - Nature Communications
Bats harbor diverse viruses but it’s less clear how they tolerate infection. Here, by characterizing innate immune responses in bat cells the authors show that IFN-beta signaling resists antagonistic ...
www.nature.com
July 1, 2025 at 1:39 PM